Elevation Oncology Announces $65M Series B Financing And Promotion Of Founder Shawn M. Leland To Chief Executive Officer
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
- $65M Series B Raise Led by New Investors venBio Partners and Cormorant Asset Management, with Participation by Boxer Capital of Tavistock Group, Janus Henderson, Samsara Biocapital, Vivo Capital, and All Existing Series A Investors -
- Shawn M. Leland, Founder of Elevation Oncology, Named Chief Executive Officer; Steve Elms, Managing Partner of Aisling Capital, to Remain Chair of Elevation Oncology Board of Directors -
NEW YORK, November 18, 2020-- Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients with ...